Diphtheria Toxoid/Pertussis, Acellular/Poliovirus Vaccine, Inactivated/Tetanus Toxoid Dosage

Usual Pediatric Dose for Poliomyelitis Prophylaxis

4 through 6 years of age:
0.5 mL by intramuscular injection. The preferred site of administration is the deltoid muscle of the upper arm. Do not administer this product intravenously, intradermally, or subcutaneously.

Usual Pediatric Dose for Diphtheria Prophylaxis

4 through 6 years of age:
0.5 mL by intramuscular injection. The preferred site of administration is the deltoid muscle of the upper arm. Do not administer this product intravenously, intradermally, or subcutaneously.

Usual Pediatric Dose for Pertussis Prophylaxis

4 through 6 years of age:
0.5 mL by intramuscular injection. The preferred site of administration is the deltoid muscle of the upper arm. Do not administer this product intravenously, intradermally, or subcutaneously.

Usual Pediatric Dose for Tetanus Prophylaxis

4 through 6 years of age:
0.5 mL by intramuscular injection. The preferred site of administration is the deltoid muscle of the upper arm. Do not administer this product intravenously, intradermally, or subcutaneously.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dialysis

Data not available

Other Comments

KINRIX may be used for the fifth dose in the DTaP immunization series and the fourth dose in the IPV.

The Advisory Committee on Immunization Practices (ACIP) recommends this as routine vaccination for use as the fifth dose in the DTaP series and the fourth dose in the IPV series in children who received DTaP (Infanrix) and/or DTaP-Hepatitis B-IPV (Pediarix) as the first 3 doses and DTaP (Infanrix) as the fourth dose. Whenever feasible, the same manufacturer should be used to provide the pertussis component; however, vaccination should not be deferred if a specific brand is not known or is not available.

See also...